Back to top
more

Brainsway (BWAY)

(Real Time Quote from BATS)

$11.85 USD

11.85
45,289

+0.01 (0.08%)

Updated Aug 7, 2025 02:44 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.75%
2Buy17.82%
3Hold9.58%
4Sell5.28%
5Strong Sell2.61%
S&P50011.30%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value A Growth D Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 37% (156 out of 246)

Industry: Medical - Products

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Zacks Equity Research

Are Medical Stocks Lagging Brainsway (BWAY) This Year?

by Zacks Equity Research

Here is how Brainsway Ltd. Sponsored ADR (BWAY) and Adma Biologics (ADMA) have performed compared to their sector so far this year.

Zacks Equity Research

Brainsway Ltd. Sponsored ADR (BWAY) Is a Great Choice for 'Trend' Investors, Here's Why

by Zacks Equity Research

Brainsway Ltd. Sponsored ADR (BWAY) could be a great choice for investors looking to make a profit from fundamentally strong stocks that are currently on the move. It is one of the several stocks that made it through our "Recent Price Strength" screen.

Zacks Equity Research

Wall Street Analysts Predict a 68.72% Upside in Brainsway Ltd. Sponsored ADR (BWAY): Here's What You Should Know

by Zacks Equity Research

The mean of analysts' price targets for Brainsway Ltd. Sponsored ADR (BWAY) points to a 68.7% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

Zacks Equity Research

BrainsWay (BWAY) Strengthens South Korean Foothold With Deep TMS

by Zacks Equity Research

BrainsWay's (BWAY) Deep TMS targets affected brain structures with a magnetic field, stimulating crucial neural networks.

Zacks Equity Research

New Strong Buy Stocks for December 1st

by Zacks Equity Research

AQST, TM, LEU, BWAY and MOD have been added to the Zacks Rank #1 (Strong Buy) List on December 1, 2023.

Zacks Equity Research

Brainsway Ltd. Sponsored ADR (BWAY) Upgraded to Strong Buy: What Does It Mean for the Stock?

by Zacks Equity Research

Brainsway Ltd. Sponsored ADR (BWAY) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Zacks Equity Research

Here's Why Momentum in Brainsway Ltd. Sponsored ADR (BWAY) Should Keep going

by Zacks Equity Research

Brainsway Ltd. Sponsored ADR (BWAY) made it through our "Recent Price Strength" screen and could be a great choice for investors looking to make a profit from stocks that are currently on the move.

Nilanjan Choudhury headshot

5 Solid Relative Price Strength Opportunities for Investors

by Nilanjan Choudhury

CLBT, BWAY, TAST, RCL and GIC are five stocks with explosive relative price strength.

Zacks Equity Research

How Much Upside is Left in Brainsway Ltd. Sponsored ADR (BWAY)? Wall Street Analysts Think 50.27%

by Zacks Equity Research

The consensus price target hints at a 50.3% upside potential for Brainsway Ltd. Sponsored ADR (BWAY). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

Zacks Equity Research

Best Momentum Stocks to Buy for November 22nd

by Zacks Equity Research

BWAY, RIGL and BROS made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on November 22, 2023.

Zacks Equity Research

New Strong Buy Stocks for November 22nd

by Zacks Equity Research

RIGL, BWAY, AVDX, IMGN and EAT have been added to the Zacks Rank #1 (Strong Buy) List on November 22, 2023.

Zacks Equity Research

Is AC Immune (ACIU) Stock Outpacing Its Medical Peers This Year?

by Zacks Equity Research

Here is how AC Immune (ACIU) and Brainsway Ltd. Sponsored ADR (BWAY) have performed compared to their sector so far this year.

Zacks Equity Research

Has AVROBIO (AVRO) Outpaced Other Medical Stocks This Year?

by Zacks Equity Research

Here is how AVROBIO, Inc. (AVRO) and Brainsway Ltd. Sponsored ADR (BWAY) have performed compared to their sector so far this year.

Zacks Equity Research

Are Medical Stocks Lagging Brainsway (BWAY) This Year?

by Zacks Equity Research

Here is how Brainsway Ltd. Sponsored ADR (BWAY) and Align Technology (ALGN) have performed compared to their sector so far this year.

Zacks Equity Research

BrainsWay (BWAY) Expands Foothold in Taiwan With Deep TMS

by Zacks Equity Research

The collaboration between BrainsWay (BWAY) and Unison Healthcare Group signifies a coordinated effort to enhance access and awareness of Deep TMS in Taiwan.

Zacks Equity Research

Is Align Technology (ALGN) Stock Outpacing Its Medical Peers This Year?

by Zacks Equity Research

Here is how Align Technology (ALGN) and Brainsway Ltd. Sponsored ADR (BWAY) have performed compared to their sector so far this year.

Zacks Equity Research

Brainsway Ltd. Sponsored ADR (BWAY) Forms 'Hammer Chart Pattern': Time for Bottom Fishing?

by Zacks Equity Research

Brainsway Ltd. Sponsored ADR (BWAY) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among Wall Street analysts in revising earnings estimates higher enhances the stock's potential for a turnaround in the near term.

Zacks Equity Research

New Strong Sell Stocks for February 7th

by Zacks Equity Research

AMD, BWAY and DCOM have been added to the Zacks Rank #5 (Strong Sell) List on February 7, 2023.

Zacks Equity Research

New Strong Sell Stocks for February 1st

by Zacks Equity Research

BWAY, CMAX and EQBK have been added to the Zacks Rank #5 (Strong Sell) List on February 1, 2023.

Zacks Equity Research

New Strong Sell Stocks for January 30th

by Zacks Equity Research

BFC, CMAX and BWAY have been added to the Zacks Rank #5 (Strong Sell) List on January 30, 2023.

Zacks Equity Research

New Strong Sell Stocks for January 26th

by Zacks Equity Research

BWAY, INDB and CNX have been added to the Zacks Rank #5 (Strong Sell) List on January 26, 2023.

Zacks Equity Research

New Strong Sell Stocks for January 24th

by Zacks Equity Research

ABM, BWAY and DXPE have been added to the Zacks Rank #5 (Strong Sell) List on January 24, 2023.

Zacks Equity Research

New Strong Sell Stocks for January 19th

by Zacks Equity Research

ABM, BWAY and DXPE have been added to the Zacks Rank #5 (Strong Sell) List on January 19, 2022.

Zacks Equity Research

New Strong Sell Stocks for January 10th

by Zacks Equity Research

BWAY, BWAY and AXL have been added to the Zacks Rank #5 (Strong Sell) List on January 10, 2023.

Zacks Equity Research

Henry Schein (HSIC) to Report Q2 Earnings: What's in Store?

by Zacks Equity Research

Henry Schein's (HSIC) Q2 performance will likely reflect continued strength in its dental and medical businesses.